SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of January, 2018

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

In December, 2017 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002 ⁽¹⁾ :

Company Name: Ambev S.A.
Group and Related Persons	( ) Board of Directors			( X ) Management		( ) Fiscal Council			( ) Technical and Consulting Committees
Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾						Quantity			%
										Same Class and Type		Total
Shares	Common						5,535,973			0.0352		0.0352
ADR	Common						336,300			0.0021		0.0021
Transac tions in the month
Securities / Derivatives		Securities Characteristics ⁽²⁾	Intermediary		Operation		Day	Quantity			Price		Volume (R$) ⁽³⁾
Shares		Common	Direct with the Company		Buy		01	6,025			2.776418		16,727.92
Shares		Common	Direct with the Company		Buy		20	55,340			17.198000		951,737.32
					Total Buy			61,365					968,465.24

Shares		Common	Ágorainvest		Sell		05	900			20.85		18,765.00
Shares		Common	Itaú Corretora		Sell		05	20,000			20.87		417,400.00
Shares		Common	Itaú Corretora		Sell		13	2,600			21.13		54,938.00
Shares		Common	Itaú Corretora		Sell		13	6,900			21.14		145,866.00
Shares		Common	XP Investimentos		Sell		22	22			21.06		463.32
Shares		Common	XP Investimentos		Sell		22	100			21.08		2,108.00
Shares		Common	XP Investimentos		Sell		22	400			21.09		8,436.00
Shares		Common	XP Investimentos		Sell		22	400			21.10		8,440.00
Shares		Common	Ágorainvest		Sell		27	900			21.27		19,143.00
Shares		Common	XP Investimentos		Sell		28	6,200			21.42		132,804.00
					Total Sell			38,422					808,363.32

Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾						Quantity			%
										Same Class and Type		Total
Shares	Common						5,558,916			0.0354		0.0354
ADR	Common						336,300			0.0021		0.0021

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

Each ADR is equivalent to 1 (one) share.

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

In December, 2017 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002 ⁽¹⁾ :

Company Name: Ambev S.A.

Group and Related Persons

( X )

Board of Directors

( )

Management

( )

Fiscal Council

( )

Technical and Consulting Committees

Initial Balance

Securities / Derivatives

Securities Characteristics ⁽²⁾

Quantity

Same Class and Type

Total

Common

26,651,682

0.1696

ADR

Common

752,519

0.0048

Transac tions in the month

Securities / Derivatives

Securities Characteristics ⁽²⁾

Intermediary

Operation

Day

Quantity

Price

Volume (R$) ⁽³⁾

Common

Direct with the Company

Exerc Options

989,925

0.78284

774,952.89

Total Buy

989,925

774,952.89

Final Balance

Securities / Derivatives

Securities Characteristics ⁽²⁾

Quantity

Same Class and Type

Total

Common

27,641,607

0.1759

ADR

Common

752,519

0.0048

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

Each ADR is equivalent to 1 (one) share.

CONSOLIDATED FORM

Management and Related Persons’ Transactions of Securities Issued by the Company

Article 11 - CVM Instruction # 358/2002

In December, 2017 the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002 ⁽¹⁾ :

Company Name: Ambev S.A.
Group and related persons	( ) Board of Directors	( ) Management	(X) Fiscal Council		( ) Technical and Consulting Committees
Initial Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾			Quantity		%
						Same Class and Type	Total
Shares	Common			7,225		0.0000	0.0000
Final Balance
Securities / Derivatives	Securities Characteristics ⁽²⁾			Quantity		%
						Same Class and Type	Tot al
Shares	Common			7,225		0.0000	0.0000

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price.

Note: These consolidated data must have information by group: Directors, Management (which have not been included in the Board of Directors), etc.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: January 10, 2018